| Eileen Bullinger, RN, MS | |
|
1915 1st Ave W, Seattle, WA 98119-2601 | |
| (206) 252-1900 | |
| (206) 252-1901 |
| Full Name | Eileen Bullinger |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 1915 1st Ave W, Seattle, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003151317 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN00054290 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Eileen Bullinger, RN, MS 1915 1st Ave W, Seattle, WA 98119-2601 Ph: () - | Eileen Bullinger, RN, MS 1915 1st Ave W, Seattle, WA 98119-2601 Ph: (206) 252-1900 |
News Archive
The Lightstone Group announced today that Siemens Corporation signed a 25,498 square-foot, long-term lease at Lightstone Group's Service Center 24 building in James Business Park in St. Rose, La. The Lightstone Group's South Louisiana portfolio, which is managed by Sealy & Company, Inc., is currently 92 percent leased.
Data from the first large U.S. study assessing the effectiveness of long-term "maintenance" therapy with lenalidomide for patients with multiple myeloma show that the drug significantly improves the time to progression and overall survival for patients with this often-deadly hematologic cancer.
Biologists have developed an efficient way to genetically modify human embryonic stem cells. Their approach, which uses bacterial artificial chromosomes to swap in defective copies of genes, will make possible the rapid development of stem cell lines that can both serve as models for human genetic diseases and as testbeds on which to screen potential treatments, they say.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its Phase II/III psoriasis trial for the Company's drug candidate CF101 did not achieve its primary endpoint.
Emerging Healthcare Solutions was encouraged by the latest breakthrough in stem cell research this week when scientists at Cincinnati Children's Hospital Medical Center announced that they've grown functioning human intestinal tissue from stem cells for the first time.
› Verified 1 days ago
Mrs. Helene Margareta Mansfield, RN, MN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 301 21st Ave E, Seattle, WA 98112 Phone: 206-252-2200 | |
Andrea Barrett-hollander, CNM Registered Nurse Medicare: Medicare Enrolled Practice Location: 5350 Tallman Ave Nw Ste 420, Seattle, WA 98107 Phone: 206-781-6161 Fax: 206-781-6208 | |
Liane Mf Richter, ARNP Registered Nurse Medicare: Medicare Enrolled Practice Location: 123 Broadway E, Seattle, WA 98102 Phone: 206-465-0316 | |
Julie Ann Crassweller, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 9934 8th Ave Sw, Seattle, WA 98106 Phone: 206-477-0044 | |
Anne Magnuson Roberts, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2124 4th Ave, Seattle, WA 98121 Phone: 206-263-8685 | |
Eric Sailor, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2600 Sw Holden St, Seattle, WA 98126 Phone: 206-933-7200 |